showed a trendp = 0.12
PFS was similar in both treatment arms, whereas OS showed a trend in favor of the panitumumab-containing arm (hazard ratio for death, 0.67; 95% CI, 0.41 to 1.11; p = 0.12).
PFS was similar in both treatment arms, whereas OS showed a trend in favor of the panitumumab-containing arm (hazard ratio for death, 0.67; 95% CI, 0.41 to 1.11; p = 0.12).